Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection

Tulathromycin is the first member of the triamilide antimicrobial drugs that has been registered in more than 30 countries. The goal of this study is to provide a potential new indication of tulathromycin for Streptococcus suis infections. We investigated the pharmacokinetic and ex vivo pharmacodyna...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yu-Feng, Peng, Hui-Min, Bu, Ming-Xiao, Liu, Ya-Hong, Sun, Jian, Liao, Xiao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627010/
https://www.ncbi.nlm.nih.gov/pubmed/29033841
http://dx.doi.org/10.3389/fphar.2017.00684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627010/
https://www.ncbi.nlm.nih.gov/pubmed/29033841
http://dx.doi.org/10.3389/fphar.2017.00684

Ejemplares similares